Aventis Pasteur Tripedia
Executive Summary
Diphtheria, tetanus and acellular pertussis vaccine approved for use as a fifth consecutive dose in the recommended DTP immunization series Aug. 24. Tripedia was previously licensed for four consecutive doses or for the completion of the DTP series following one or more doses of whole-cell DTP, but not for all fives doses consecutively